1Laupacis A, Albers G, Dalen J, et al. Antithrombotic therapy in atrial fibrillation. Chest. 1995;108(Supp14):352S-359S.
2Hart RG. Benavente O, McBride R. Pearce LA. Antithrombotic therapy to revent stoke in patients with atrial fibrillation. Ann Intern Med. 1999;131:492-501.
3Risk factors for stroke and efficacy of antithromboric therapy in atrial fibrillation. Arch Intern Med.1994;154:1449-1457.
4Petersen P, Boysen G, Godtfredsen J. Andersen ED,Andersen B. Placebo-controlled, randomised trial of warfarin and aspirin for preventin of thromboembolic complications in chronic atrial fibrillation: the Copenhagen AFASAK study. Lancet 1989;1:175-178.
5Stroke Prevention in Atrial Fibrillation Stuc final results. Circulation 1991;84:527-539.
6Ezekowitz MD. Bridgers SL, James KE, et al, or the Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigator. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. N Engl J Med. 1992;327:1406-1412.
7Laupacis A, Albers G, Dalen J, Dunn MJ, Jacobsen AK. Singer DE. Antithrombotic therapy in atrial fibrillation. Chest 1998;114(9 suppl):5795-5885.
8Stroke Prevention in Abial Fibrillation Investigators.Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention In Atrial Fibrllation II Study. Lancet 1994;3,43:687 -691.
9Hart RG. Pearce LA, McBride R, Rothbart RM, Asinger RW, for the Stroke Prevention in Atrial Fibrillation (SPAF) Investigators. Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation Stroke. 1999;30:1223-1229.
10The SPAF III Writing Committee for the Stroke Prevention in Atrial Fibrillation Investigators. Patients with nonvalvular atrial fibrillation at low risk of stroke during treatment with aspirin: Stroke Prevention in Atrial Fibrillation III Study. JAMA, 1998;279:1273-1277.
同被引文献2
1Puererfellner,H.Recent developments in cardiovascular drug therapy:Treatment of atrial arrhythmias with new class Ⅲ drugs and beyond[J].Curr Med Chem Cardiovasc Hematol Agents,2004,2(1):79.
2Tendera M,Wnuk-Wojnar AM,Graffo,et al.Efficacy and safety of dofetilide in the prevention of symptomatic episodes of paroxysmal supraventricular tachycardia:a 6-month double-blind comparison with propafenone and placebo[J].Am Heart J,2001,142(1):93.
